COLOMBO NICOLETTA

Lorusso, D., Xiang, Y., Hasegawa, K., Scambia, G., Leiva, M., Ramos-Elias, P., et al. (2025). Pembrolizumab or Placebo With Chemoradiotherapy Followed by Pembrolizumab or Placebo for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): Overall Survival Results From a Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial. OBSTETRICAL & GYNECOLOGICAL SURVEY, 80(2), 93-95 [10.1097/01.ogx.0001108096.71273.16]. Dettaglio

De Vitis, L., Schivardi, G., Delfrati, S., Biffi, B., Viscardi, A., Rosanu, M., et al. (2025). The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(1) [10.1016/j.ijgc.2024.100024]. Dettaglio

Valenza, C., Mongillo, M., Visconti, M., Katrini, J., Trapani, D., Boldrini, L., et al. (2025). Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study. GYNECOLOGIC ONCOLOGY, 194(March 2025), 11-17 [10.1016/j.ygyno.2025.01.014]. Dettaglio

Franciosa, G., Nieddu, V., Battistini, C., Caffarini, M., Lupia, M., Colombo, N., et al. (2025). Quantitative Proteomics and Phosphoproteomics Analysis of Patient-Derived Ovarian Cancer Stem Cells. MOLECULAR & CELLULAR PROTEOMICS, 24(5) [10.1016/j.mcpro.2025.100965]. Dettaglio

Concin, N., Matias-Guiu, X., Cibula, D., Colombo, N., Creutzberg, C., Ledermann, J., et al. (2025). ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025. THE LANCET ONCOLOGY, 26(8), 423-435 [10.1016/S1470-2045(25)00167-6]. Dettaglio